BRAF mutation detection and identification by cycling temperature capillary electrophoresis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• BRAF mutations are prevalent in human cancers, notably melanomas (approx. 70%) and colon carcinomas (approx. 15%).
• Accurate and efficient detection of these mutations is crucial for diagnosis and treatment strategies.
• Current methods may be costly or not amenable to high-throughput screening.

Purpose of the Study:

• To develop and validate a sensitive, cost-effective method for identifying BRAF exon 15 mutations.
• To screen melanoma cell lines and colon biopsy samples for specific BRAF mutations.
• To establish a denaturing capillary electrophoresis (CE) standard for mutation detection without sequencing.

Main Methods:

• Utilized denaturing capillary electrophoresis (CE) coupled with polymerase chain reaction (PCR) for mutation analysis.
• Screened 30 melanoma cell lines and 221 colon biopsy samples for BRAF exon 15 mutations.
• Investigated NRAS mutations in BRAF-negative cell lines to assess co-occurrence.

Main Results:

• Identified BRAF exon 15 mutations in 70% (21/30) of melanoma cell lines, including p.Val600Asp, p.Val600Arg, and p.Val600Glu.
• Detected p.Asp594Gly and p.Val600Glu BRAF mutations in colon biopsy samples.
• Found no overlap between BRAF and NRAS mutations within the same cell line.

Conclusions:

• Denaturing CE is a sensitive, cost-effective, and high-throughput method for detecting BRAF exon 15 mutations.
• The developed CE standard allows for mutation identification without the need for confirmatory sequencing.
• This assay has potential for large-scale studies to determine the clinical utility of BRAF and RAS mutations.